Cholesterol reduction using manufactured foods high in monounsaturated fatty acids: a randomized crossover study
- PMID: 10615219
Cholesterol reduction using manufactured foods high in monounsaturated fatty acids: a randomized crossover study
Abstract
In two separate studies, the cholesterol-lowering efficacy of a diet high in monounsaturated fatty acids (MUFA) was evaluated by means of a randomized crossover trial. In both studies subjects were randomized to receive either a high-MUFA diet or the control diet first, which they followed for a period of 8 weeks; following a washout period of 4-6 weeks they were transferred onto the opposing diet for a further period of 8 weeks. In one study subjects were healthy middle-aged men (n 30), and in the other they were young men (n 23) with a family history of CHD recruited from two centres (Guildford and Dublin). The two studies were conducted over the same time period using identical foods and study designs. Subjects consumed 38% energy as fat, with 18% energy as MUFA and 10% as saturated fatty acids (MUFA diet), or 13% energy as MUFA and 16% as saturated fatty acids (control diet). The polyunsaturated fatty acid content of each diet was 7%. The diets were achieved by providing subjects with manufactured foods such as spreads, 'ready meals', biscuits, puddings and breads, which, apart from their fatty acid compositions, were identical for both diets. Subjects were blind to which of the diets they were following on both arms of the study. Weight changes on the diets were less than 1 kg. In the groups combined (n 53) mean total and LDL-cholesterol levels were significantly lower at the end of the MUFA diet than the control diet by 0.29 (SD 0.61) mmol/l (P < 0.001) and 0.38 (SD 0.64) mmol/l (P < 0.0001) respectively. In middle-aged men these differences were due to a mean reduction in LDL-cholesterol of -11 (SD 12)% on the MUFA diet with no change on the control diet (-1.1 (SD 10)%). In young men the differences were due to an increase in LDL-cholesterol concentration on the control diet of +6.2 (SD 13)% and a decrease on the MUFA diet of -7.8 (SD 20)%. Differences in the responses of middle-aged and young men to the two diets did not appear to be due to differences in their habitual baseline diets which were generally similar, but appeared to reflect the lower baseline cholesterol concentrations in the younger men. There was a moderately strong and statistically significant inverse correlation between the change in LDL-cholesterol concentration on each diet and the baseline fasting LDL-cholesterol concentration (r -0.49; P < 0.0005). In conclusion, diets in which saturated fat is partially replaced by MUFA can achieve significant reductions in total and LDL-cholesterol concentrations, even when total fat and energy intakes are maintained. The dietary approach used to alter fatty acid intakes would be appropriate for achieving reductions in saturated fat intakes in whole populations.
Comment in
-
Ways to reduce saturated fat intake.Br J Nutr. 1999 Jun;81(6):421-3. Br J Nutr. 1999. PMID: 10615215 No abstract available.
Similar articles
-
The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults.Eur J Clin Nutr. 2001 Oct;55(10):908-15. doi: 10.1038/sj.ejcn.1601234. Eur J Clin Nutr. 2001. PMID: 11593354 Clinical Trial.
-
Effects of two lipid-lowering, carotenoid-controlled diets on the oxidative modification of low-density lipoproteins in free-living humans.Clin Sci (Lond). 2003 Sep;105(3):355-61. doi: 10.1042/CS20030050. Clin Sci (Lond). 2003. PMID: 12780345 Clinical Trial.
-
Should mono- or poly-unsaturated fats replace saturated fat in the diet?Eur J Clin Nutr. 1992 Jun;46(6):429-36. Eur J Clin Nutr. 1992. PMID: 1639051 Clinical Trial.
-
Diet and coronary heart disease.Hum Nutr Clin Nutr. 1982;36(6):413-27. Hum Nutr Clin Nutr. 1982. PMID: 6298152 Review.
-
[Changes in the serum lipid levels in males with ischemic heart disease under the effect of diets with various cholesterol and fat contents].Orv Hetil. 1995 Jun 11;136(24):1267-9. Orv Hetil. 1995. PMID: 7596584 Review. Hungarian.
Cited by
-
Successful manipulation of the quality and quantity of fat and carbohydrate consumed by free-living individuals using a food exchange model.J Nutr. 2009 Aug;139(8):1534-40. doi: 10.3945/jn.108.103374. Epub 2009 Jun 23. J Nutr. 2009. PMID: 19549752 Free PMC article. Clinical Trial.
-
DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial.Am J Clin Nutr. 2014 Jul;100(1):88-97. doi: 10.3945/ajcn.113.081133. Epub 2014 May 14. Am J Clin Nutr. 2014. PMID: 24829493 Free PMC article. Clinical Trial.
-
Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco).Lipids Health Dis. 2013 Jul 20;12:107. doi: 10.1186/1476-511X-12-107. Lipids Health Dis. 2013. PMID: 23870174 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical